Rajat Kumar

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Hervé Dombret, John F. Seymour, Aleksandra Butrym et al. · Blood · 2015 · 1.1K citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +2

Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study

S S Rastogi, Sukesh Rao Sankineani, Hira Lal Nag et al. · MUSCULOSKELETAL SURGERY · 2013 · 108 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +13

Patient‐related factors independently impact overall survival in patients with myelodysplastic syndromes: an <scp>MDS</scp>‐<scp>CAN</scp> prospective study

Rena Buckstein, Richard A. Wells, Nancy Zhu et al. · British Journal of Haematology · 2016 · 97 citations · Full text

Medicine, Biostatistics, Frailty +16

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

Arjun Law, María Queralt Salas, Wilson Lam et al. · Biology of Blood and Marrow Transplantation · 2018 · 94 citations · Full text

Medicine, Hematology, Immunology +17

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

John F. Seymour, Hartmut Döhner, Aleksandra Butrym et al. · BMC Cancer · 2017 · 73 citations · Full text

Medicine, Oncology, Pharmacology +15